Study guide
2.2 Healing Phases, Healing vs Non-Healing, and Biofilm
WOCNCB Certified Wound Care Nurse CWCN
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current CWCN Exam Facts 1.2 Eligibility: Traditional, Experiential, and WTA-C Credit 1.3 Fees, Retakes, Recertification, and Test Strategy
2 Skin Biology, History & Systemic Factors
2.1 Integumentary Anatomy and Skin Barrier 2.2 Healing Phases, Healing vs Non-Healing, and Biofilm 2.3 History, Psychosocial Factors, Nutrition, and Pain 2.4 Systemic Healing Factors and Medications
3 Diagnostics and the Focused Wound Exam
3.1 Vascular, Laboratory, Imaging, and Perfusion Studies 3.2 Wound Measurement, Periwound Signs, and Dermatologic Differentials 3.3 When and How to Culture a Wound
4 Pressure Injury Pathophysiology and Staging
4.1 Pressure Injury Pathophysiology and Risk Tools 4.2 NPIAP Stages 1 through 4 4.3 Unstageable, DTPI, MDRPI, and Mucosal Injuries
5 Lower-Extremity and Special Etiologies
5.1 Venous / LEVD Ulcer Assessment 5.2 Arterial / LEAD Ulcer Assessment and PAD Testing 5.3 Neuropathic Foot Ulcers, Charcot, and Wagner Grading 5.4 Mixed Disease, Atypical, Surgical, Traumatic, and Burn Wounds
6 Prevention and Support Surfaces
6.1 Risk-Based Prevention: Moisture, Nutrition, Mobility, Cognition 6.2 Repositioning, Shear Reduction, and Seating 6.3 Support Surface Types and Selection
7 Offloading, Moisture, and Skin Products
7.1 Offloading and Protective Footwear 7.2 MASD/IAD, MARSI Prevention, and Skin Care Products 7.3 Friction, Heel Protection, and Preventing Treatment Complications
8 Wound-Care Principles, Pain, and Studies
8.1 Moisture Balance, Dead Space, and Periwound Protection 8.2 Recommending Pain Management Modalities 8.3 Obtaining Cultures and Recommending Studies
9 Cleansing and Wound Bed Preparation
9.1 Wound Cleansing Regimens 9.2 TIME: Infection, Moisture, and Edge Optimization 9.3 Chemical Cauterization Indications
10 Debridement Modalities
10.1 Debridement Types, Indications, and Contraindications 10.2 Conservative Sharp vs Surgical/Excisional Debridement 10.3 Autolytic, Enzymatic, Biological, and Mechanical Debridement
11 Topical Therapies
11.1 Hydrating Dressings: Hydrogels, Films, Hydrocolloids 11.2 Absorbent Dressings: Foams, Alginates, Hydrofibers 11.3 Antimicrobials, Odor Control, and Periwound Integrity
12 Compression Therapy
12.1 Compression Types, Indications, and Contraindications 12.2 Static vs Dynamic Compression Application 12.3 Mixed Arterial-Venous Disease and Compression Safety
13 Advanced and Adjunctive Therapies
13.1 Negative Pressure Wound Therapy 13.2 HBOT, Bioengineered Tissue, and Leech Therapy 13.3 Hydrotherapy, Pulsed Lavage, Mist, Maggot Therapy, and Total Contact Casting
14 Patient-Centered Goals
14.1 Patient-Centered Care, Access, and Cultural Beliefs 14.2 Preventive, Palliative, Maintenance, and Curative Goals 14.3 Writing Patient-Focused Skin and Wound Goals
15 Evaluation, Modification, and Documentation
15.1 Evaluating Treatment Effectiveness 15.2 Interpreting Response and Modifying the Plan 15.3 Documentation, CMS Quality Context, and Surveillance
16 Patient and Caregiver Education
16.1 Health Literacy, Goals, and Teach-Back 16.2 Educating on Procedures, Skin Care, and Diagnostic Results 16.3 Modifiable Risk Factors and Resource Access
17 Educating Other Clinicians
17.1 Teaching Skin and Wound Principles, Procedures, and Goals 17.2 Infection Control, Repositioning, Moisture, Nutrition, and Trauma Avoidance for Teams 17.3 Recommending Non-Invasive and Invasive Next Steps
18 Collaboration, Referral, and Handoff
18.1 Support, Supply Access, Post-Acute Care, and Service Referrals 18.2 Referring for Studies and Specialty Consults 18.3 Handoff Communication Across Settings
2.2 Healing Phases, Healing vs Non-Healing, and Biofilm
Key Takeaways Explain This Topic AI
Acute repair moves through hemostasis, inflammation, proliferation, and maturation; tensile strength returns only to about 80% of original over months.
Healing signs include granulation, decreasing dimensions, and resurfacing; non-healing includes infection, biofilm, epibole, and stalled measurements for about 2–4 weeks.
Biofilm is a polymicrobial community in extracellular polymeric substance with tolerance to systemic antibiotics; treat with repeated debridement plus topical antimicrobials, not a single swab of surface slime.
Chronic wounds often show MMP excess relative to TIMPs, destroying matrix and growth factors.
Primary intention approximates edges; secondary intention heals an open defect; tertiary intention is delayed closure.
Last updated: September 2026
2.2 Healing Phases, Healing vs Non-Healing, and Biofilm
Quick Answer: A healing full-thickness wound granulates, shrinks, and resurfaces. A non-healing wound is often infected, biofilm-laden, or sealed by epibole. Biofilm needs frequent debridement plus topical antimicrobials; systemic antibiotics do not reliably kill organisms sitting in slime.
Knowledge areas 010306, 010307, and 010308 sit together on purpose. If you cannot tell hemostasis from proliferation, you will misread a dry clot as failure. If you cannot tell healing from non-healing, you will keep the same weekly foam on a rolled-edge ulcer for two months and call it conservative care.
Hemostasis
Immediately after injury, vessels constrict and platelets aggregate. The fibrin clot is a provisional matrix and a reservoir of growth factors (PDGF, TGF-β, EGF, and others). Hemostasis is brief in a clean acute wound. In a patient on anticoagulants, hemostasis is noisy: you plan for bleeding with debridement (section 2.4) rather than assuming the inflammatory cascade will look textbook.
Inflammation
Neutrophils arrive first and phagocytose debris and bacteria. Macrophages follow, cleaning the bed and signaling fibroblasts and endothelial cells to move into proliferation. In an acute wound this phase lasts days, not weeks. Persistent inflammation is not more healing. Chronic wound fluid is often a soup of matrix metalloproteinases (MMPs) that outrun their tissue inhibitors (TIMPs) . Excess MMPs chew the extracellular matrix and growth factors you are trying to preserve with dressings. That MMP/TIMP imbalance is a biochemical way of saying the wound is stuck in inflammation.
Clinical inflammation you should respect includes spreading erythema (or color change), induration, new or increasing pain, purulence, and fever. Local contamination without host response is not automatically a reason to start culture-driven intravenous antibiotics. Host response plus stalled healing is.
Proliferation: granulation, angiogenesis, contraction, epithelialization
Four processes run together:
Granulation — fibroblasts deposit a vascular, collagen-rich matrix. Healthy granulation is beefy red and slightly granular, not pale, dusky, or friable and bloody at a light touch.
Angiogenesis — new capillaries feed that matrix. Poor perfusion (PAD, nicotine, edema that chokes capillaries) starves this step.
Contraction — myofibroblasts pull full-thickness edges centripetally. Contraction is useful in a sacral cavity and dangerous over a joint if it predicts contracture.
Epithelialization — keratinocytes migrate on a moist, level surface. Dry crust, necrotic eschar, and a closed or rolled edge (epibole) stop migration. Islands of epithelium appear only if appendages survive (partial-thickness, section 2.1).
Maturation and remodeling
Collagen is remodeled, cross-linked, and shifted from early type III toward type I. This takes months , not the day the surface looks pink. Classic teaching is that tensile strength returns to about 80% of original —never 100%. A closed abdominal dehiscence site or a filled pressure injury is still a weak scar. Educate against premature heavy lifting, shear, and stripping the new epithelium with aggressive adhesive.
Healing versus non-healing characteristics
- Finding Healing Non-healing / stalled
- Bed Beefy granulation Pale, friable, necrotic, or hypergranular
- Dimensions Decreasing length, width, and/or depth Unchanged or increasing over about 2–4 weeks
- Edge Attached, advancing epithelium Epibole, undermining, cliff-like closed edge
- Exudate Decreasing, serous to serosanguinous Increasing, malodorous, purulent
- Surface Progressive resurfacing Persistent slime film that reforms after cleansing
A practical rule used in wound programs: failure to progress in about 2–4 weeks (assuming a healable wound with an appropriate plan) should trigger a search for infection, biofilm, ischemia, unrelieved pressure, malnutrition, or the wrong diagnosis. Acute versus chronic is not a calendar tattooed at day 14; it is a failure of orderly phase progression.
Biofilm
Biofilm is a polymicrobial community attached to the wound surface and protected by extracellular polymeric substance (EPS) —the slime. Organisms in biofilm show tolerance to systemic antibiotics that might kill the same species in planktonic (free-floating) blood-stream infection. A swab of the shiny film often grows whatever is on the surface and does not map the community in the EPS, nor does a single culture tell you the biofilm is gone.
CWCN-level management logic:
Mechanically disrupt the community with frequent debridement (conservative sharp when competent and indicated; other methods when sharp is not). One clinic visit of scraping is not a biofilm program.
Use topical antimicrobials or antimicrobial dressings as an adjunct after disruption, then reassess.
Do not treat the swab of slime as the only intervention, and do not assume a 10-day oral antibiotic course will finish a chronic biofilm venous ulcer.
Watch for rapid return of a shiny, adherent film within a day of cleansing—that pattern is more biofilm than simple serous scab.
Biofilm and MMP excess travel together: chronic inflammation feeds protease activity, proteases keep the bed from granulating, and the unhealed surface remains a biofilm habitat.
Primary, secondary, and tertiary intention
Primary intention: edges are approximated (sutures, staples, glue). Minimal granulation; epithelializes as a fine line if perfusion and technique are good.
Secondary intention: the defect is left open. It must granulate, contract, and epithelialize from the margins. Most chronic ulcers you manage are secondary-intention problems.
Tertiary intention (delayed primary closure): the wound is left open until contamination or edema is controlled, then closed. Think contaminated surgical wound, not a 6-month venous ulcer you suddenly suture.
Mixing these terms on the exam is a common miss: a dehisced surgical incision healing as an open crater is secondary intention, not primary, even though it started in the operating room.
Scenario
Mr. Kowalski has a left gaiter venous ulcer, 4.2 × 3.1 × 0.3 cm, present 12 weeks. Measurements have not changed in 3 weeks. The edge is rolled and closed. After clinic cleansing, a shiny film is gone; at the next visit the same film is back. Compression has been inconsistent because of pain. You do not document slowly healing and reorder the same hydrocolloid. You name stalled healing with epibole and likely biofilm , plan edge management and serial debridement, add a topical antimicrobial strategy, fix compression and edema, and look for MMP-driven chronic inflammation rather than a new dressing brand as the entire plan. If host signs of spreading infection appear, that is a separate systemic-therapy decision—not a substitute for biofilm disruption.